In this third instalment of the five-part, festive series of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Mark Andrews, investment director of life sciences funds at British Patient Capital (BPC), discussing the vitally hot topic of investment in life sciences.
Gene therapy and market access: the pharmaphorum podcast
AMR research and Matoke Pharma: the pharmaphorum podcast
GSK and digital disruption: the pharmaphorum podcast
Ipsen on neurotoxin research: the pharmaphorum podcast
Successful medical marketing teams: the pharmaphorum podcast
Biotech strategy and nanomedicine: the pharmaphorum podcast
Commercialising orphan drugs: the pharmaphorum podcast
The future biosimilar landscape: the pharmaphorum podcast
Nimble consumer healthcare innovation: the pharmaphorum podcast
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Unexplainable
Stuff To Blow Your Mind
Speaking of Psychology